Open AccessTocilizumab Induces Rapid, Sustained Improvement of Inflammatory Markers in COVID-19, With Clinical Improvement in Most Patients
Author(s) -
S.J. Morin,
Chinmay Jani,
Arashdeep Rupal,
Harpreet Singh,
Daniel Bourque,
Robert C. Colgrove
Publication year - 2021
Publication title -
american journal of therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.349
H-Index - 62
eISSN - 1536-3686
pISSN - 1075-2765
DOI - 10.1097/mjt.0000000000001412
Subject(s) - medicine , tocilizumab , covid-19 , virology , rheumatoid arthritis , disease , outbreak , infectious disease (medical specialty)